Chiara Montemurro
Chiara Montemurro
1Larry L. Hillblom Islet Research Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90024 USA
1,#,
Hiroshi Nomoto
Hiroshi Nomoto
1Larry L. Hillblom Islet Research Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90024 USA
1,#,
Lina Pei
Lina Pei
1Larry L. Hillblom Islet Research Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90024 USA
1,#,
Vishal S Parekh
Vishal S Parekh
2Department of Pharmacology and Brehm Diabetes Research Center, University of Michigan, Ann Arbor, MI 48105 USA
2,
Kenny E Vongbunyong
Kenny E Vongbunyong
1Larry L. Hillblom Islet Research Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90024 USA
1,
Suryakiran Vadrevu
Suryakiran Vadrevu
2Department of Pharmacology and Brehm Diabetes Research Center, University of Michigan, Ann Arbor, MI 48105 USA
2,
Tatyana Gurlo
Tatyana Gurlo
1Larry L. Hillblom Islet Research Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90024 USA
1,
Alexandra E Butler
Alexandra E Butler
1Larry L. Hillblom Islet Research Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90024 USA
1,
Rohan Subramaniam
Rohan Subramaniam
1Larry L. Hillblom Islet Research Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90024 USA
1,
Eleni Ritou
Eleni Ritou
3Division of Endocrinology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90024 USA
3,
Orian S Shirihai
Orian S Shirihai
3Division of Endocrinology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90024 USA
3,
Leslie S Satin
Leslie S Satin
2Department of Pharmacology and Brehm Diabetes Research Center, University of Michigan, Ann Arbor, MI 48105 USA
2,
Peter C Butler
Peter C Butler
1Larry L. Hillblom Islet Research Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90024 USA
1,
Slavica Tudzarova
Slavica Tudzarova
1Larry L. Hillblom Islet Research Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90024 USA
4Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90024 USA
1,4,✉
1Larry L. Hillblom Islet Research Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90024 USA
2Department of Pharmacology and Brehm Diabetes Research Center, University of Michigan, Ann Arbor, MI 48105 USA
3Division of Endocrinology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90024 USA
4Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90024 USA
Subject terms: Mechanisms of disease, Type 2 diabetes
© The Author(s) 2019
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
